NEC and Chugai Pharmaceutical use AI to reduce drug combination prediction time for cancer…
Graph-based AI system developed by NEC may cut prediction time by 50%, offering support in identifying effective drug combinations…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Miltenyi Biotec and BIRAC partner to build cell and gene therapy capacity in India
The collaboration aims to boost India’s CGT capabilities through local manufacturing, research, skill development, and innovation…
IIT Delhi launches executive programme for industry 5.0 to equip professionals for future-ready…
Offered in collaboration with Jaro Education, the 6-month online programme integrates Industry 5.0 technologies with healthcare…
Boehringer Ingelheim launches single-dose poultry vaccine in India covering three major diseases
The new hatchery-administered vaccine provides combined protection against Bursal, Newcastle, and Marek’s disease for broilers,…
Gerresheimer enhances pharma packaging registration with comprehensive product database
Web-based audit-proof system supports faster drug approvals by providing detailed documentation for solid, liquid, and ophthalmic…
Theos Life Sciences launches northeast operations to expand pharma access and employment
Company announces entry into Assam with focus on affordable healthcare, regional research, and job creation
IDMA to host IDMA CARES – Creating accountable, respectful, empowered & safe workplaces for the…
Novel business-insights by Government stakeholders, subject-matter experts, industry stalwarts and NextGen leaders to create…
Madhavbaug partners with Ministry of Ayush to promote yoga for cardiac and diabetes prevention ahead…
Madhavbaug to conduct yoga camps across Maharashtra as part of Ministry of Ayush’s International Day of Yoga initiative to support…
Sheffield scientists and AstraZeneca develop new machine learning model for inverse protein folding
New AI model MapDiff outperforms current methods in inverse protein folding, offering potential applications in therapeutic…
Myasthenia gravis market across 7MM set to grow at 5.3% CAGR between 2024 and 2034, forecasts…
Growth driven by rising diagnosed prevalence and launch of late-stage pipeline therapies, despite pressure from biosimilar…